Reimbursement Scheme Veoza®
Reimbursement Scheme for VEOZA® (fezolinetant) 45 mg for the treatment of moderate to severe vasomotor symptoms (VMS) associated...
Update Reimbursement Scheme Elvanse®
TBR Nederland hereby informs you that from now on the conditions regarding the Reimbursement Scheme Elvanse® 20 mg, 30 mg, 40 mg,...
Update Reimbursement Scheme Jardiance® 10mg - Chronic Kidney Disease
From February 1, 2024, the use of Jardiance® (empagliflozin) in adult patients with chronic kidney disease, with and without...
Reimbursement Scheme Kesimpta®
The health insurer does not fully reimburse Kesimpta® 20mg solution for injection in pre-filled pen. The producer of this medicine...
Update Reimbursement Scheme Forxiga® 10mg and Xigduo® 5mg
TBR Nederland hereby informs you that from now on the conditions regarding the Reimbursement Scheme Forxiga® 10mg and Xigduo® 5mg...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine